Literature DB >> 15582583

Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.

Niklas Piening1, Petra Weber, Armin Giese, Hans Kretzschmar.   

Abstract

The conversion of cellular prion protein (PrP(C)) to the disease-associated misfolded isoform (PrP(Sc)) is an essential process for prion replication. This structural conversion can be modelled in protein misfolding cyclic amplification (PMCA) reactions in which PrP(Sc) is inoculated into healthy hamster brain homogenate, followed by cycles of incubation and sonication. In serial transmission PMCA experiments it has recently been shown that the protease-resistant PrP obtained in vitro (PrPres) is generated by an autocatalytic mechanism. Here, serial transmission PMCA experiments were compared with serial transmission reactions lacking the sonication steps. We achieved approximately 200,000-fold PrPres amplification by PMCA. In contrast, although initial amplification was comparable to PMCA reactions, PrPres levels quickly dropped below detection limit when samples were not subjected to ultrasound. These results indicate that aggregate breakage is essential for efficient autocatalytic amplification of misfolded prion protein and suggest an important role of aggregate breakage in prion propagation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15582583     DOI: 10.1016/j.bbrc.2004.11.039

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  De novo generation of prion strains.

Authors:  David W Colby; Stanley B Prusiner
Journal:  Nat Rev Microbiol       Date:  2011-09-26       Impact factor: 60.633

Review 2.  Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C).

Authors:  Andrew C Gill; Sonya Agarwal; Teresa J T Pinheiro; James F Graham
Journal:  Prion       Date:  2010-10-20       Impact factor: 3.931

3.  Cell-free formation of misfolded prion protein with authentic prion infectivity.

Authors:  Petra Weber; Armin Giese; Niklas Piening; Gerda Mitteregger; Achim Thomzig; Michael Beekes; Hans A Kretzschmar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

4.  Cyclic amplification of prion protein misfolding.

Authors:  Marcelo A Barria; Dennisse Gonzalez-Romero; Claudio Soto
Journal:  Methods Mol Biol       Date:  2012

5.  Inefficient induction and spread of seeded tau pathology in P301L mouse model of tauopathy suggests inherent physiological barriers to transmission.

Authors:  Paramita Chakrabarty; Vincent J Hudson; Amanda N Sacino; Mieu My Thi Brooks; Simon D'Alton; Jada Lewis; Todd E Golde; Benoit I Giasson
Journal:  Acta Neuropathol       Date:  2015-05-16       Impact factor: 17.088

6.  Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity.

Authors:  Victoria Lewis; Cathryn L Haigh; Colin L Masters; Andrew F Hill; Victoria A Lawson; Steven J Collins
Journal:  Mol Neurodegener       Date:  2012-04-26       Impact factor: 14.195

Review 7.  The expanding universe of prion diseases.

Authors:  Joel C Watts; Aru Balachandran; David Westaway
Journal:  PLoS Pathog       Date:  2006-03       Impact factor: 6.823

8.  Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies.

Authors:  Hasier Eraña; Jorge M Charco; Michele A Di Bari; Carlos M Díaz-Domínguez; Rafael López-Moreno; Enric Vidal; Ezequiel González-Miranda; Miguel A Pérez-Castro; Sandra García-Martínez; Susana Bravo; Natalia Fernández-Borges; Mariví Geijo; Claudia D'Agostino; Joseba Garrido; Jifeng Bian; Anna König; Boran Uluca-Yazgi; Raimon Sabate; Vadim Khaychuk; Ilaria Vanni; Glenn C Telling; Henrike Heise; Romolo Nonno; Jesús R Requena; Joaquín Castilla
Journal:  PLoS Pathog       Date:  2019-10-23       Impact factor: 6.823

9.  Chemical chaperone and inhibitor discovery: potential treatments for protein conformational diseases.

Authors:  Jian-Hua Zhao; Hsuan-Liang Liu; Hsin-Yi Lin; Chih-Hung Huang; Hsu-Wei Fang; Shiao-Shing Chen; Yih Ho; Wei-Bor Tsai; Wen-Yih Chen
Journal:  Perspect Medicin Chem       Date:  2007-12-11

10.  Reversible unfolding of infectious prion assemblies reveals the existence of an oligomeric elementary brick.

Authors:  Angélique Igel-Egalon; Mohammed Moudjou; Davy Martin; Alexandra Busley; Tina Knäpple; Laetitia Herzog; Fabienne Reine; Nad'a Lepejova; Charles-Adrien Richard; Vincent Béringue; Human Rezaei
Journal:  PLoS Pathog       Date:  2017-09-07       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.